Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.

Na K, Qiu M, Zhang T, Li Y, Duan Y, Li Y, Li J, Li Y, Han Y

Open source

DOI
10.1055/a-2922-8191
Published
2026 Aug 11
Container
Thrombosis and haemostasis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2922-8191,
  title = {Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.},
  author = {Na K and Qiu M and Zhang T and Li Y and Duan Y and Li Y and Li J and Li Y and Han Y},
  year = {2026},
  journal = {Thrombosis and haemostasis},
  doi = {10.1055/a-2922-8191},
  url = {https://doi.org/10.1055/a-2922-8191}
}

RIS

TY  - JOUR
TI  - Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.
AU  - Na K
AU  - Qiu M
AU  - Zhang T
AU  - Li Y
AU  - Duan Y
AU  - Li Y
AU  - Li J
AU  - Li Y
AU  - Han Y
PY  - 2026
JO  - Thrombosis and haemostasis
DO  - 10.1055/a-2922-8191
UR  - https://doi.org/10.1055/a-2922-8191
ER  - 

APA

K, N., M, Q., T, Z., Y, L., Y, D., Y, L., J, L., Y, L., & Y, H. (2026). Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.. Thrombosis and haemostasis. https://doi.org/10.1055/a-2922-8191

Source records